| Cat.No. |
Chemical Name |
MolFormula |
| HR473106 |
Butyl 4-(4-chloro-3-nitrophenyl)-7-(3,4-dimethoxyphenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate |
C29H31ClN2O7 |
| HR472721 |
Benzyl 6-hydroxy-3-azabicyclo[3.1.0]hexane-3-carboxylate |
C13H15NO3 |
| HR472616 |
Benzo[c][1,2,5]oxadiazol-4-ylmethanamine |
C7H7N3O |
| HR472344 |
Benzyl 4-(2-chloro-5-nitrophenyl)-7-(3,4-dimethoxyphenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate |
C32H29ClN2O7 |
| HR471508 |
Bis(2-iodothiophen-3-yl)methanol |
C9H6I2OS2 |
| HR471407 |
Benzyl 4-bromo-3-methoxythiophene-2-carboxylate |
C13H11BrO3S |
| HR470042 |
Bis(6-Bromoquinoline)sulfate |
C18H14Br2N2O4S |
| HR469987 |
Bromosporine |
C17H20N6O4S |
| HR469984 |
B-Raf inhibitor 1 dihydrochloride |
C26H21Cl3N8 |
| HR469958 |
BIBR 1532 |
C21H17NO3 |
| HR469912 |
BFH772 |
C23H16F3N3O3 |
| HR469911 |
Bax inhibitor peptide V5 |
C27H50N6O6S |
| HR469910 |
Briciclib |
C19H23O10PS |
| HR469881 |
BRD7116 |
C28H36N2O4S |
| HR469872 |
BH3I-1 |
C15H14BrNO3S2 |
| HR469846 |
Bafetinib |
C30H31F3N8O |
| HR469822 |
BRD73954 |
C16H16N2O3 |
| HR469801 |
BEC Hydrochloride |
C5H13BClNO4S |
| HR469744 |
BRL 54443 |
C14H18N2O |
| HR469595 |
Bitopertin R-Enantiomer |
C21H20F7N3O4S |
| HR469578 |
Bay 61-3606 |
C20H18N6O3 |
| HR469566 |
Bestatin trifluoroacetate |
C18H25F3N2O6 |
| HR469435 |
Biie-0246 |
C49H57N11O6 |
| HR469376 |
BRACO 19 3HCl |
C35H46Cl3N7O2 |
| HR469373 |
Bi-3663 |
C44H42F3N7O12 |
| HR469197 |
Bay 60-6583 |
C19H17N5O2S |
| HR469157 |
BET-BAY 002 S-Enantiomer |
C22H18ClN5O |
| HR469148 |
Boc-Val-Ala-PAB-PNP |
C27H34N4O9 |
| HR469115 |
Benzyl (4-formylthiazol-2-yl)carbamate |
C12H10N2O3S |
| HR468968 |
Bleomycin A5 Hydrochloride(1:x) |
C57H90ClN19O21S2 |
